Finding new ways to activate pain relief channels in the body
Discovery and characterization of selective GIRK1/2 activators and their evaluation in preclinical models of pain
This study is exploring new ways to help people with chronic pain feel better without using opioids, by testing a special type of medication that targets certain channels in the body to provide pain relief safely.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10816384 on NIH RePORTER |
What this research studies
This research focuses on developing new, non-opioid therapies for managing chronic pain, which is often poorly treated with current medications. The team is investigating G protein-gated inwardly rectifying potassium (GIRK) channels, which play a role in pain relief and are linked to the effectiveness of opioid medications. By testing selective GIRK1/2 activators in preclinical models, the researchers aim to enhance pain relief without the side effects associated with opioids, such as addiction and cognitive impairment. The study involves administering these activators to animal models to assess their effectiveness and safety.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing chronic pain who are seeking alternative treatments to opioids.
Not a fit: Patients who do not experience chronic pain or have conditions unrelated to pain management may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective pain management options for patients suffering from chronic pain.
How similar studies have performed: Other research has shown promise in targeting GIRK channels for pain relief, indicating that this approach may lead to significant advancements in pain management.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Hopkins, Corey R. — University of Nebraska Medical Center
- Study coordinator: Hopkins, Corey R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.